New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase - Bellarosa, D; Antonelli, G; Bambacioni, F (Antiviral Res, 1996)
et al.